Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. - Wikidata - awgldk - TriplyDB

Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy.

Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy.

http://www.wikidata.org/entity/Q45200908

about

Apolipoprotein O is mitochondrial and promotes lipotoxicity in heart A critical role for eukaryotic elongation factor 1A-1 in lipotoxic cell death SLC27 fatty acid transport proteins Lean heart: Role of leptin in cardiac hypertrophy and metabolism Insulin receptor signaling in normal and insulin-resistant states Cardiac energy metabolic alterations in pressure overload-induced left and right heart failure (2013 Grover Conference Series)How exercise may amend metabolic disturbances in diabetic cardiomyopathy Diabetic cardiomyopathy: bench to bedside Mechanisms of sudden cardiac death: oxidants and metabolism Topology of the yeast fatty acid transport protein Fat1p: mechanistic implications for functional domains on the cytosolic surface of the plasma membrane.Obesity and cancer progression: is there a role of fatty acid metabolism?The Use of SGLT-2 Inhibitors in Type 2 Diabetes and Heart Failure Very long-chain acyl-CoA synthetase 3: overexpression and growth dependence in lung cancer Novel role of FATP1 in mitochondrial fatty acid oxidation in skeletal muscle cells Functional domains of the fatty acid transport proteins: studies using protein chimeras Obesity reduces left ventricular strains, torsion, and synchrony in mouse models: a cine displacement encoding with stimulated echoes (DENSE) cardiovascular magnetic resonance study.New approaches in small animal echocardiography: imaging the sounds of silence.Quantitative analysis of the magnitude and time delay of cyclic variation of myocardial backscatter from asymptomatic type 2 diabetes mellitus subjects.High-fat-diet-induced obesity and heart dysfunction are regulated by the TOR pathway in Drosophila Gene expression of sternohyoid and diaphragm muscles in type 2 diabetic rats.Different effects of palmitoyl-L-carnitine and palmitoyl-CoA on mitochondrial function in rat ventricular myocytes.Cardiac expression of microsomal triglyceride transfer protein is increased in obesity and serves to attenuate cardiac triglyceride accumulation.Association and interaction of PPAR-complex gene variants with latent traits of left ventricular diastolic function Molecular determinants of cardiac transient outward potassium current (I(to)) expression and regulation Fatty acid transport protein 1 (FATP1) localizes in mitochondria in mouse skeletal muscle and regulates lipid and ketone body disposal.Lipotoxicity in the heart.Acyl-CoA synthesis, lipid metabolism and lipotoxicity.Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-alpha transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-alpha activators Measurement and interpretation of electrocardiographic QT intervals in murine hearts Long-chain acyl-CoA synthetases and fatty acid channeling Elevated plasma free fatty acids are associated with sudden death: a prospective community-based evaluation at the time of cardiac arrest Lower Expression of SLC27A1 Enhances Intramuscular Fat Deposition in Chicken via Down-Regulated Fatty Acid Oxidation Mediated by CPT1A.Luminal Na(+)/H (+) exchange in the proximal tubule Molecular determinants of the cardiometabolic phenotype.Substrate-enzyme competition attenuates upregulated anaplerotic flux through malic enzyme in hypertrophied rat heart and restores triacylglyceride content: attenuating upregulated anaplerosis in hypertrophy.Cardiac remodeling in obesity.PPARγ-induced cardiolipotoxicity in mice is ameliorated by PPARα deficiency despite increases in fatty acid oxidation.Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome.MR proton spectroscopy for myocardial lipid deposition quantification: a quantitative comparison between 1.5T and 3T.Phospholipid homeostasis regulates lipid metabolism and cardiac function through SREBP signaling in Drosophila

P2860

Q24294870-486246D9-4380-4EE3-8C09-988FC53AD537 Q24540224-687D5892-A2A9-4AEB-90E4-EF5880287845 Q24601518-6088F298-B863-4500-97BB-91DE9ABB0979 Q26785951-C8CE1D8A-2AAE-4C75-9205-0103FF4E4D61 Q26823171-0E55E90E-D09E-4CE3-AA25-7C6F3B1C271F Q26825047-2AE9D2E8-B66A-4BC1-B77F-2CFD1C582E13 Q26863272-01CDB3B4-4BA0-4ECC-AE17-C1B00EEBE572 Q26997062-98E43E7B-377C-405E-B69C-23CEE0AA7913 Q27024176-8ED55008-DB9B-4EB5-960D-A2127424DDC5 Q27931619-3BA64E09-16FD-4A19-826F-A39FED40688C Q28081152-578616AD-24C9-42FB-B444-43730CF57004 Q28082343-D4480D9E-A93D-425A-A9BF-8AC0D6117A67 Q28534769-44960196-77AF-4F65-BA23-C0E6B7D9CE62 Q28574936-494766E4-2E13-4D45-A627-5AF0D65052E7 Q28594735-4765EA9B-9CA2-4956-A7ED-3CD9C7C5EB39 Q30415371-6206E7E4-270D-4B95-B747-21E6E5DC246F Q30461404-193C992B-95E2-4F11-A36A-ACB63F4B1483 Q30479827-E815F1A2-5610-4683-B137-2653A05C0E38 Q30497986-3208D88A-40AD-411C-BA4A-A8014C71D102 Q31143158-7B7E0246-FE40-4AE7-897F-F744BC8C35C5 Q33333376-83CC0F6A-1561-4575-9131-2CB57BE65E52 Q33434386-FDE07215-FC1C-4509-A84C-57E6B6C09E4A Q33567318-2E165C23-B55B-4F2C-8F1E-612D1D13DD32 Q33618573-1B53721D-0D4B-4250-95BC-7BB0D4A8339C Q33654802-41EB130D-24FF-4AAA-9E89-A8B01D8EE3BD Q33665107-27D9A9E9-ECB5-47D9-9DD2-DB57C905C5B0 Q33665741-E9BC29F7-BECC-453A-B83A-33B5A9D096C6 Q33675244-8C8D38E7-FED2-4FA0-AC8B-0FB6B3678F99 Q33701971-A4C53870-3C68-462A-B0D9-4554D4431854 Q33757925-A4500E86-4BBD-4FA7-A17F-442678E2E64C Q33835566-CB9A4D48-6472-4F29-9AF8-F6544D72D1A7 Q33849841-621C2623-0F94-4689-AB49-5C46CFE6D76B Q33884278-3D88B777-130F-40E0-8702-95754155C677 Q33921392-126F7C96-1219-4CBD-8D68-6B3306E0402A Q34012909-09C17860-C16B-42AC-91B4-00F998AB303A Q34043589-CD733A22-9346-4467-AFCE-F6DBB6ADA0FB Q34162103-48A7DBC7-A474-4764-82B8-4A15A5A0217F Q34207748-E5376E40-DD62-449D-B1B1-EE1D6132599F Q34349173-B2187D46-A170-4B2A-973A-206D25D0CC4D Q34497344-6C1C6FDB-E1DA-426A-B7C4-C0CC807C8317

P2860

Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy.

http://www.wikidata.org/entity/Q45200908

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Transgenic expression of fatty ...... uses lipotoxic cardiomyopathy.

@en

Transgenic expression of fatty ...... uses lipotoxic cardiomyopathy.

@nl

type

label

Transgenic expression of fatty ...... uses lipotoxic cardiomyopathy.

@en

Transgenic expression of fatty ...... uses lipotoxic cardiomyopathy.

@nl

prefLabel

Transgenic expression of fatty ...... uses lipotoxic cardiomyopathy.

@en

Transgenic expression of fatty ...... uses lipotoxic cardiomyopathy.

@nl

P1433

Q45200908-DE66B224-CD6C-4D0B-9DAA-97B3883A61A9

P1476

Q45200908-5B6B117B-115D-4B00-BA7B-8758DBFBDF4C

P2093

Q45200908-03129424-A07B-45C6-AFA2-BBA685C57E5A

Q45200908-053AB961-6CC6-4C00-B8CA-D12BC982CA15

Q45200908-06D8FA52-C988-4664-A7FB-D2098A90C6FA

Q45200908-0A60A6EF-5333-4E3C-AACB-F6EA259F735A

Q45200908-1C205320-D439-4648-B418-DD09989CBDAF

Q45200908-228A23AB-DF48-4411-940C-94AC92C01419

Q45200908-285684EE-7DF7-4728-AD44-865814CB96B8

Q45200908-2945FDEA-E95B-43A5-A3BC-C480DA482C54

Q45200908-2E89A94C-9B40-4953-828E-A0F70EECE2A6

Q45200908-44CC68A1-2302-4E28-ADA3-EB9D0E5A0F62

P304

Q45200908-EA91B614-0A78-49BE-8288-BDBB4F64F84E

P31

Q45200908-5ADC736C-A219-4FE3-A9FC-E4C358211A08

P356

Q45200908-124A8B35-AA57-43FE-BFDE-A5DD564E1F99

P433

Q45200908-905E0E9A-9F0B-4132-BD2B-E4EFCA1041CA

P478

Q45200908-70255433-7E68-419F-A201-404B99C82EB7

P577

Q45200908-F56F98D7-AB54-4B15-8EDA-806BD8DDFB53

P5875

Q45200908-E1DB1403-4522-4A9C-85CB-B4F1F86E79A6

P698

Q45200908-8F298790-13EF-46DB-8ACB-5B39123A8B92

P921

Q45200908-C2E55C10-F49A-4DD0-BAA4-4E8ADB916781

P356

01.RES.0000154079.20681.B9

P1433

Circulation Research

P1476

Transgenic expression of fatty ...... uses lipotoxic cardiomyopathy.

@en

P2093

Attila Kovacs

http://www.w3.org/2001/XMLSchema#string

Carla J Weinheimer

http://www.w3.org/2001/XMLSchema#string

Daniel S Ory

http://www.w3.org/2001/XMLSchema#string

Haodong Xu

http://www.w3.org/2001/XMLSchema#string

Hsiu-Chiang Chiu

http://www.w3.org/2001/XMLSchema#string

Jean E Schaffer

http://www.w3.org/2001/XMLSchema#string

Jeanne M Nerbonne

http://www.w3.org/2001/XMLSchema#string

Kathryn A Yamada

http://www.w3.org/2001/XMLSchema#string

Krista M Olson

http://www.w3.org/2001/XMLSchema#string

Michael Courtois

http://www.w3.org/2001/XMLSchema#string

P304

225-233

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.RES.0000154079.20681.B9

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P577

2004-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8111255

http://www.w3.org/2001/XMLSchema#string

P698

15618539

http://www.w3.org/2001/XMLSchema#string

P921